Skip to NavigationSkip to content

News

Former ImClone boss Samuel Waksal has agreed to pay $800,000 to settle some of the charges brought against him by the US Securities & Exchange...
GlaxoSmithKline is to raise the issue of Chief Executive Jean-Pierre Garnier pay once again this week, saying it is intended as part of a wider...
The European Commission has restarted its review of Pfizer merger with Pharmacia, and now expects to complete the investigation of the $60 billion...
A Government inquiry into the safety of the SSRI class of antidepressants has been scrapped and must start again from scratch after potential...
AstraZeneca have filed the first European marketing application for an atypical antipsychotic as a treatment for manic episodes related to bipolar...
Eli Lilly have launched Cialis, the first serious rival to blockbuster erectile dysfunction drug Viagra amid a flurry of media coverage.
Aventis has reined in its 2003 forecasts and warned investors that the pace of its growth would slow to a igh single digitincrease.
Irish pharmaceutical company Elan made a larger than expected loss of $2.39 billion last year.
Pharmaceutical companies attempting to keep up with Pfizer industry lead have a battle on their hands, according to analysts Datamonitor.
A serious lack of progress in EU moves to reform pharmaceutical regulation is now jeopardising key objectives, according to European industry body...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches